Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
about
Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemiaObesity, fatty liver disease and intestinal microbiotaToll-like receptors in pathophysiology of liver diseasesMolecular Pathogenesis of NASHGut Microbiota and Host Reaction in Liver DiseasesCCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitisVitamin D deficiency in chronic liver disease.Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver.Toll-like receptors in secondary obstructive cholangiopathy.Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral originMicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate CellsToll-like receptors in liver fibrosis: cellular crosstalk and mechanismsInflammatory stress potentiates emodin-induced liver injury in rats.High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.Lipopolysaccharide mediates immuno-pathological alterations in young chicken liver through TLR4 signalingSnake Venom Disintegrin Inhibits the Activation of Toll-Like Receptors and Alleviates Sepsis through Integrin alphaVbeta3 Blockade.Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury.The functional role of microRNAs in alcoholic liver injury.Correlation of Asp299Gly and Thr399Ile polymorphisms in toll-like receptor 4 gene with digestive cancer risk: A meta-analysis.Crosstalk Between Transforming Growth Factor Beta-2 and Toll-Like Receptor 4 in the Trabecular Meshwork.The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.Toll-like receptors and liver disease.Immune and inflammatory pathways in NASH.Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunologyPathophysiology of portal hypertension and its clinical links.Establishment of minimal positive-control conditions to ensure brain safety during rapid development of emergency vaccines.Starring role of toll-like receptor-4 activation in the gut-liver axis.Toll-Like Receptor 4 Inhibition Improves Oxidative Stress and Mitochondrial Health in Isoproterenol-Induced Cardiac Hypertrophy in Rats.Liver involvement in human immunodeficiency virus infection.Anti-inflammatory effect of procyanidin B1 on LPS-treated THP1 cells via interaction with the TLR4-MD-2 heterodimer and p38 MAPK and NF-κB signaling.Adverse outcome pathway development from protein alkylation to liver fibrosis.Aging of the Liver: What This Means for Patients with HIV.The activation of TLR7 regulates the expression of VEGF, TIMP1, MMP2, IL-6, and IL-15 in Hela cells.Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients.Early tyrosine phosphorylation events following adenosine A2A receptor in human neutrophils: identification of regulated pathways.
P2860
Q26769611-49BA201E-1B2C-464C-BFB8-DD78FB46F84BQ26826919-E4326BA0-B70A-449E-8BC1-5D982E530273Q26997784-3723DA40-30A7-49B8-865E-25A4E3888D81Q28070077-827AE393-074E-4063-A83F-ACF7D0AF66E2Q28071265-467A430C-1CBA-4FC4-9466-F86A37E21682Q28083295-3E5A50A1-76E3-49C4-B8DC-CF8E96A37F55Q33882408-F42CA4D3-939A-4FF7-B62A-F23A83A229ABQ34728285-FB1252E8-0686-4C11-869B-F0ECDBC2A691Q35246561-13F01FC8-D795-48CD-957E-876FA47032A8Q35495496-996AAC78-CF6B-4D3F-9A46-F49F4532AB59Q35599450-9EB55F1F-48C1-4631-9FEB-BA318C21FABBQ35861037-D2760D0D-A76B-4E16-A972-6732C0498C1BQ35977675-5A88915F-FB89-43D3-9E0C-5CC65F37CD65Q36192206-186E24D3-6447-4DA6-BBA5-360010AE5112Q36255749-C1D155FC-FB46-4867-8C22-A6472F75024AQ36292136-F0D62AD8-14DC-4C91-A377-CB400E0C7F33Q36700074-892251BB-C211-42B2-AC84-A02321BA4E40Q36800214-F8BC798E-7E35-4811-A624-3E2C4DF4B968Q37166770-C4EF0096-3CB8-4AE0-91A4-C0C9228F784BQ37437190-013BF36B-6B62-4A4A-84D9-DA4EE2307BB7Q37545034-0903ED26-5B0A-4C7C-8FC4-5A35F23A0460Q37595286-B193152E-80E9-47E0-BF65-362BA8EE4EDAQ37641119-2AD01E70-A6E6-4F66-B17B-BBE4A9C93296Q37731910-F42EFDC7-8292-408C-99AB-C0E9833A66E5Q38074434-BC930FF5-1406-422A-ACDA-B8E2DBEB3006Q38151944-FE6624FA-E9D7-4B5C-B317-BB8B70580828Q38192633-432953C9-09D1-4968-A0DD-87B153D27CB5Q38311151-6BB6046A-4B24-4FBF-8BFF-CD8ADEB5640DQ38371453-C74C4479-856D-46D0-891D-194030D2A831Q38634886-D1227DEB-986B-4EC9-B482-28BE39BEB2DAQ38645789-FF4FC4FD-62F3-45E0-B35B-EDBF5B3B584CQ38687402-D3F7EB8C-B444-4246-B7F7-29AEF38DAE5BQ38852184-72BF4EDF-F159-4AC0-91E2-AD93F6E7FE38Q38868161-58A9AED7-2560-4F32-BF14-370E7A7DA836Q38932043-6EF043CA-6C5A-4991-A234-89EAFF7834E8Q38936312-63D232D5-1450-4583-A41B-15D56CDB59DCQ39042435-E964940C-8886-4E80-A442-114AE7279B82Q39333658-F0FC25D7-177D-4DE9-B9A6-0C301A1DE72CQ39419036-00B101E3-908B-4928-A151-E3DAEEBEBEF8Q40339462-1D013702-4FB6-4E10-9214-57EBF3228D9F
P2860
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@ast
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@en
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@nl
type
label
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@ast
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@en
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@nl
prefLabel
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@ast
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@en
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@nl
P2860
P356
P1476
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
@en
P2093
Jinsheng Guo
Scott L Friedman
P2860
P2888
P356
10.1186/1755-1536-3-21
P577
2010-10-21T00:00:00Z
P5875
P6179
1049360912